JEAN CHRISTOPHE
Reporting owner on Forms 3, 4 and 5, CIK 1378435.
JEAN CHRISTOPHE reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RYTM · RHYTHM PHARMACEUTICALS, INC.CIK 1649904 | director | 1 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-17 | M exercised | +10,000 | $34.89 | 21,712 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-17 | S sold | -5,000 | $106.81 | 16,712 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-17 | S sold | -2,500 | $110 | 14,212 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Common Stock | 2026-11-17 | S sold | -2,500 | $115 | 11,712 | Form 4 |
| RYTM · RHYTHM PHARMACEUTICALS, INC.Stock Options (Right to Buy), derivative | 2026-11-17 | M exercised | -10,000 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001649904-26-000030 | RHYTHM PHARMACEUTICALS, INC. | 2026-11-18 |